Esma Sukurica

Weight Loss or Muscle Loss? Cellular Mechanisms and Clinical Strategies for Preserving Lean Mass During GLP ‐1‐Based Therapy

ABSTRACT Glucagon‐like peptide‐1 receptor agonists and newer dual‐ and triple‐incretin receptor agonists have transformed obesity treatment by producing substantial and sustained weight loss. However, reported reductions in lean body mass have raised concerns about potential skel...